We did not detect any difference in the percentage of F4/80+ macrophages, Ly6C+ monocytes, B220+ B cells, Nk1.1+ NK cells, CD4+ or CD8+ T cells among CD45+ immune cells in the tumor (Supplementary Fig. 4d). This evidence concerns the gene PTPRC and neoplasm.